| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2797305 | Diabetes Research and Clinical Practice | 2011 | 4 Pages |
Abstract
We analyzed the medical records of 884 type 2 DM patients who were taking different antiplatelet agents for more than 2 years. Based on the records, occurrences of cardiovascular events for 10 years were evaluated. The composite disease-free survival rate for cilostazol monotherapy group was similar to aspirin subgroup (p = 0.133).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Sang Youl Rhee, Young Seol Kim, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung Woon Kim, Jin-Woo Kim,